Clinical Trial Update: Immunotherapy of Melanoma Patients [Phase 1]

View source ↗

Summary

A Phase 1 immunotherapy trial for melanoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Snippet

Sponsor: Centre Hospitalier Universitaire Vaudois | Conditions: Melanoma | Phase 1 | Status: COMPLETED